Research Funding and Policy Implications in the Further Consolidated Appropriations Act, 2024
The act includes $47.1 billion for the National Institutes of Health (NIH), $378 million (0.8%) below the FY 2023 enacted level.
Read moreThe National Cancer Institute will showcase research from four different Cancer Moonshot initiatives that support the 10 recommendations of the Blue Ribbon Panel (BRP) report. The BRP report describes 10 transformative research recommendations for achieving the Cancer Moonshot's goal of making a decade's worth of progress in cancer prevention, diagnosis and treatment in just five years.
The four presentations will inform the community about the progress of Cancer Moonshot-funded projects, provide outreach related to Cancer Moonshot projects, enhance discussions and collaborations related to Cancer Moonshot research, and promote the sharing of data from Cancer Moonshot initiatives. The four topics to be covered are:
Registration for each seminar is required and is open now. For more information, contact Katie Grady, American College of Radiology® Government Affairs Director.
Research Funding and Policy Implications in the Further Consolidated Appropriations Act, 2024
The act includes $47.1 billion for the National Institutes of Health (NIH), $378 million (0.8%) below the FY 2023 enacted level.
Read moreCancer Moonshot Announces New Investments and Actions Working With ARPA-H
President Joe Biden and First Lady Jill Biden convened a meeting of representatives from various federal agencies working on the Cancer Moonshot initiative Sept. 13, where it was announced that $240 million will be made available to researchers and innovators this year for cancer-related projects. The additional investments will aim to accelerate new ways to prevent, detect, treat and survive cancer.
Read moreARPA-H Aims to Fight Cancer With CUREIT Project
CUREIT will fund up to $24 million to fight cancer with the goal of developing generalizable mRNA platforms to treat diverse diseases.
Read more